Portage Biotech (NASDAQ:ALP) & Soluna (NASDAQ:SLNH) Head-To-Head Review

Portage Biotech (NASDAQ:ALPGet Free Report) and Soluna (NASDAQ:SLNHGet Free Report) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations.

Valuation & Earnings

This table compares Portage Biotech and Soluna”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Portage Biotech $97,000.00 40.94 -$38.63 million ($8.18) -0.02
Soluna $42.08 million 6.45 -$53.41 million ($1.12) -0.99

Portage Biotech has higher earnings, but lower revenue than Soluna. Soluna is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 23.2% of Soluna shares are owned by institutional investors. 10.1% of Soluna shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Portage Biotech and Soluna’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Portage Biotech N/A N/A N/A
Soluna -182.16% -52.19% -32.17%

Volatility & Risk

Portage Biotech has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, Soluna has a beta of 5.13, meaning that its stock price is 413% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Portage Biotech and Soluna, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Portage Biotech 1 2 0 0 1.67
Soluna 1 1 1 0 2.00

Portage Biotech currently has a consensus price target of $0.25, indicating a potential upside of 47.75%. Soluna has a consensus price target of $4.00, indicating a potential upside of 260.36%. Given Soluna’s stronger consensus rating and higher probable upside, analysts plainly believe Soluna is more favorable than Portage Biotech.

Summary

Soluna beats Portage Biotech on 8 of the 14 factors compared between the two stocks.

About Portage Biotech

(Get Free Report)

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company’s product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

About Soluna

(Get Free Report)

Soluna Holdings, Inc. together with its subsidiaries, engages in the mining of cryptocurrency through data centers. It operates through two segments, Cryptocurrency Mining and Data Center Hosting. The company also operates in the blockchain business. In addition, the company develops and builds modular data centers that use for cryptocurrency mining. Further, it provides data center hosting services, including electrical power and network connectivity to cryptocurrency mining customers. The company was formerly known as Mechanical Technology Inc and as changed to Soluna Holdings, Inc. Soluna Holdings, Inc. was incorporated in 1961 and is headquartered in Albany, New York.

Receive News & Ratings for Portage Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Portage Biotech and related companies with MarketBeat.com's FREE daily email newsletter.